|Articles|November 2, 2003
- Pharmaceutical Technology-11-02-2003
- Volume 27
- Issue 11
Routine Sample Size for a Retest Procedure
Author(s)Jeffrey D. Hofer
This article discusses a straightforward approach that scientists may use to descide how many nonsuspect restest results are required to provide sufficient evidence to overcome an initial suspect result.
Advertisement
Articles in this issue
about 22 years ago
FDA Will Drive Changes for Contract Businessabout 22 years ago
In the Spotlight--Decemberabout 22 years ago
Novemember 2003about 22 years ago
FDA Seeks Risk-Based Inspection Programabout 22 years ago
November 2003about 22 years ago
Clearing Regulatory Hurdlesabout 22 years ago
Improving Protein Capture for Transgenic Drug ProcessingNewsletter
Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.
Advertisement
Advertisement
Advertisement
Trending on Pharmaceutical Technology
1
Using AI and Molecular Dynamics to Overcome the Poor Solubility Challenge
2
Why Context Matters in Validating Biomarker Assays for Bioanalysis
3
Targeted high resolution metabolite screening workflows
4
An approach to streamline and simplify the identification of crucial metabolites from targeted protein degraders
5
